Adaptive cohort design and LAT1 expression scale: study protocol for a Phase 2a trial of QBS72S in breast cancer brain metastases. Taiwo R, Harary PM, Trinh TTH, Granucci M, et al. BMC Cancer 2025;25:1316.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Taiwo R, Harary PM, Trinh TTH, Granucci M, et al. Adaptive cohort design and LAT1 expression scale: study protocol for a Phase 2a trial of QBS72S in breast cancer brain metastases. BMC Cancer 2025;25:1316.
PMID: 40813655